Skip to content

Effects of IASTM With and Without CT on Pain, ROM, and Functional Disability in Post-Operative Knee Stiffness Patients

Effects of Instrumental Soft Tissue Mobilization Technique With and Without Conservative Treatment on Pain , Range of Motion and Functional Disability in Post Operative Knee Stiffness Patients

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06551922
Enrollment
84
Registered
2024-08-13
Start date
2024-01-28
Completion date
2024-12-21
Last updated
2025-01-31

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Knee Pain Chronic, Pain, Pain, Joint, Pain, Postoperative

Keywords

Range of motion, Knee Stiffness, Functional Disability, Conservative treatment, Instrument-Assisted Soft Tissue Mobilization

Brief summary

This single-blinded randomized control study aimed to determine the effects of instrumental soft tissue mobilization technique with and without conservative treatment in post-operative knee stiffness patients. This study recruited 84 participants who fulfilled the inclusion criteria and were randomly divided into experimental and control groups using the lottery method. The assessor was unaware of the treatment given to both groups. Data were collected at baseline, at the end of the third week, and at the end of the sixth week. Baseline assessments were conducted before the intervention. Post-intervention assessments were conducted immediately after the intervention. This study aimed to investigate the effectiveness of IASTM, both with and without traditional conservative treatment methods, in improving pain, range of motion, and functional ability in patients experiencing post-operative knee stiffness. By examining these factors, we gained valuable insights into the potential of IASTM as a therapeutic intervention for this challenging condition.

Detailed description

Instrument-Assisted Soft Tissue Mobilization (IASTM) is emerging as a valuable tool for physiotherapists, offering a range of benefits for both practitioners and patients. By integrating IASTM with traditional methods, physiotherapists can elevate the standard of care, improve patient outcomes, and even contribute to a healthier community. Study Design: * Randomized Control Trial Screening: * Patients were screened to meet inclusion criteria. The consent form was taken from patients and then randomly allocated into two groups ( 42 in each group). Randomization: * Patients fulfilling the inclusion criteria were randomly divided into experimental and control groups using the lottery method. Blinding: * The study was single-blinded. The assessor was unaware of the treatment given to both groups. Assessment: * Data was collected at baseline, at the end of the third week and the end of 6th week. Baseline assessments were conducted before the intervention. Post-intervention assessments were conducted immediately after the intervention. Intervention: * Group A (Instrumental Soft Tissue Mobilization Technique with Conservative Treatment) * Group B (Conservative Treatment Only) Progress Monitoring: * Treatment intensity and exercise difficulty were progressively adjusted for both groups throughout the intervention based on participant tolerance and progress. Ethical Considerations: * This study has received ethical approval from the Institutional Review Board (IRB). Informed consent was obtained from all participants. Data Analysis: * Statistical software was used to analyze the data, with appropriate tests employed based on data normality to compare outcomes between groups.

Interventions

COMBINATION_PRODUCTInstrumental Soft Tissue Mobilization Technique with Conservative Treatment

TENS: Apply TENS for 10 minutes on the greater trochanter and the area just above the lateral knee joint line, adhesive electrodes were positioned. Frequency: 3 times per week. Duration: 90 seconds- 2 minutes on each muscle (Purbia, 2023). Technique: A therapist uses Ergon tools to apply gentle pressure and strokes along the targeted muscles and fascial tissues. Different IASTM techniques, like stroking, raking, and hooking, address specific tissue restrictions. The therapist should continue the IASTM technique for 5-10 minutes, or until the stiffness in the knee is reduced (Mubashar et al., 2022; Purbia, 2023). Conservative Treatment: Stretching exercises for the hamstrings and quadriceps to improve flexibility and reduce tension. Affected iliotibialband. Hold for 30 seconds. Uncross your legs and stand up straight again. Repeat four more times (Mubashar et al., 2022).

COMBINATION_PRODUCTConservative Treatment

TENS: Apply TENS for 10 minutes on the greater trochanter and the area just above the lateral knee joint line, adhesive electrodes were positioned. Stretching exercises with hold for 30 seconds. Uncross your legs and stand up straight again (Mubashar et al., 2022). Quadriceps Strengthening: Perform exercises like straight leg raises, seated leg press and squats to strengthen (Lim & Al-Dadah, 2022). Hamstring Strengthening: Include exercises like leg curls to strengthen the hamstring muscles (Lim & Al-Dadah, 2022). Calf Strengthening: Perform calf raises to strengthen the calf muscles (Lim & Al-Dadah, 2022). Balance Exercises: Incorporate balance exercises like single-leg stands on a foam pad (Lim & Al-Dadah, 2022). Ice Therapy: Apply ice packs to the affected knee for 15-20 minutes (Lim & Al-Dadah, 2022).

Sponsors

University of Lahore
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Masking description

The single-blinded assessor was utilized to minimize bias in outcome measurements. The assessor was unaware of the intervention group assignment for each participant.

Intervention model description

* Group A (Instrumental Soft Tissue Mobilization Technique with Conservative Treatment) * Group B (Conservative Treatment Only)

Eligibility

Sex/Gender
ALL
Age
25 Years to 50 Years
Healthy volunteers
No

Inclusion criteria

* Participants aged 25 to 50 years (Meena et al., 2023) * Participants of both genders (Meena et al., 2023) * Participants who have undergone post-operative knee stiffness surgery (Meena et al., 2023) * Patients having knee fracture (Poliakov et al., 2020).

Exclusion criteria

* Patients with total knee replacement (Poliakov et al., 2020). * Participants with knee osteoarthritis or other knee conditions not related to post-operative knee stiffness (Meena et al., 2023) * Participants with other joint conditions not related to the knee (Mezey et al., 2023) * Post-operative knee stiffness patients with comorbidities that may affect the outcome of the study (Mezey et al., 2023)

Design outcomes

Primary

MeasureTime frameDescription
Pain Intensity6 weeks (baseline, third week and then at the end of the sixth week)Pain level measured using a visual analog scale. It consists of a 10-centimeter line with endpoints labeled to represent the two extremes of the experience being measured. For pain, the typical endpoints are no pain on the left and worst imaginable pain on the right. For pain, a score of 0 means no pain, while a score of 10 represents the worst imaginable pain.
Range of motion6 weeks (baseline, third week and then at the end of the sixth week)Range of motion measured using a goniometer

Secondary

MeasureTime frameDescription
Functional disability6 weeks (baseline, third week and then at the end of the sixth week)Functional disability measured using the Lower Extremity Functional Scale. The scale consists of 20 items that assess the patient's ability to perform various activities, such as walking, running, and climbing stairs. The objective of the LEFS is to measure patients' initial function, ongoing progress, and outcome for a wide range of lower-extremity conditions. The maximum total score is 80, indicating no functional limitations.The minimum score is 0, indicating extreme limitations. The lower the total score, the greater the disability

Countries

Pakistan

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026